Review
Published on 10 Jul 2025
Beyond the heart: a review exploring non-cardiovascular effects of vasoactive agents
in Cardiovascular and Smooth Muscle Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1533437
Type at least 3 characters
1,322 articles
Original Research
Published on 10 Jul 2025
Calycosin suppresses the activating effect of granulocyte-macrophage-colony-stimulating factor-producing T helper cells on macrophages in experimental atherosclerosis
in Cardiovascular and Smooth Muscle Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1607349
Original Research
Published on 07 Jul 2025
Bitter taste receptor agonists induce vasorelaxation in porcine coronary arteries
in Cardiovascular and Smooth Muscle Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1578913
- 289 views
Case Report
Accepted on 04 Jul 2025
A case report of 'Two-hit' Digenic Mutations in PAH: Role of PADN in Management
in Cardiovascular and Smooth Muscle Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1601777
Review
Published on 04 Jul 2025
Harnessing the therapeutic value of Tanshinone IIA: a breakthrough therapy in cardiovascular diseases
in Cardiovascular and Smooth Muscle Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1620152
- 316 views
Original Research
Accepted on 03 Jul 2025
Fc-Elabela mitigates heart failure without liver and renal toxicity in mice
in Cardiovascular and Smooth Muscle Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1555728
- 160 views
Review
Published on 03 Jul 2025
Adenosine and adenosine receptors: a “double-edged sword” in cardiovascular system
in Cardiovascular and Smooth Muscle Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1538680
- 419 views
Review
Published on 03 Jul 2025
Targeting NADPH oxidase-driven oxidative stress in diabetic cardiomyopathy: mechanisms and therapeutic perspectives
in Cardiovascular and Smooth Muscle Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1610429
- 370 views
Original Research
Accepted on 02 Jul 2025
HDL ATTENUATES ANG II-AT1R-EGFR SIGNALING AND REVERSES VASCULAR REMODELING IN SPONTANEOUSLY HYPERTENSIVE RATS
in Cardiovascular and Smooth Muscle Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1617420
Original Research
Accepted on 30 Jun 2025
What is the best clinical management strategies for cardiomyopathy? an umbrella review of systematic review and meta-analysis
in Cardiovascular and Smooth Muscle Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1544121
Review
Accepted on 30 Jun 2025
Copper homeostasis and cuproptosis in myocardial infarction: molecular mechanisms, treatment strategies and potential therapeutic targets
in Cardiovascular and Smooth Muscle Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1525585
- 611 views
Original Research
Accepted on 30 Jun 2025
Exploring the biological basis for the identification of different syndromes in ischemic heart failure based on joint multi-omics analysis
in Cardiovascular and Smooth Muscle Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1641422
Case Report
Accepted on 30 Jun 2025
Low Molecular Weight Induced Heparin-Induced Thrombocytopenia with Multisite Embolism: Successful Management with Argatroban and Dabigatran-A Case Report and Literature Review
in Cardiovascular and Smooth Muscle Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1573840
Original Research
Accepted on 27 Jun 2025
Gastrodin reduces myocardial ischemia/reperfusion injury via Transgelin2/CNPase-mediated apoptosis regulation
in Cardiovascular and Smooth Muscle Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1604408
- 214 views
Original Research
Published on 26 Jun 2025
Pedunculoside targets P2X7R to protect against myocarditis by regulating the NLRP3/PIP2/MAPK signaling pathway
in Cardiovascular and Smooth Muscle Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1589298
- 514 views
Review
Published on 25 Jun 2025
Efficacy of different dosages of common uric acid-lowering medications in gout patients: a network meta-analysis of randomized control trials
in Cardiovascular and Smooth Muscle Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1565530
- 493 views